Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Resectable Esophageal Cancer × Cetuximab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 129 Head and Neck Neoplasms 68 Squamous Cell Carcinoma of Head and Neck 64 Rectal Neoplasms 41 Colonic Neoplasms 36 Carcinoma, Non-Small-Cell Lung 32 Neoplasm Metastasis 30 Neoplasms 21 Carcinoma, Squamous Cell 19 Pancreatic Neoplasms 15 Lung Neoplasms 14 Esophageal Neoplasms 14 Stomach Neoplasms 12 Laryngeal Neoplasms 11 Recurrence 10 Mouth Neoplasms 9 Esophageal Squamous Cell Carcinoma 8 Breast Neoplasms 8 Adenocarcinoma Of Esophagus 8 Tongue Neoplasms 7 Oropharyngeal Neoplasms 7 Hypopharyngeal Neoplasms 6 Colorectal Cancer Metastatic 6 Adenocarcinoma of Lung 6 Uterine Cervical Neoplasms 5 Salivary Gland Neoplasms 5 Nasopharyngeal Carcinoma 5 Laryngeal Diseases 5 Carcinoma 4 Adenocarcinoma, Bronchiolo-Alveolar 4

Interventions

Chemoradiotherapy 1 Cetuximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00827671 2018-03-09

TRACC

UMC Utrecht

Phase 2 Terminated

Gastrointestinal

Resectable Esophageal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡